The approach to Thrombotic Thrombocytopenic Purpura (TTP) involves the prompt initiation of plasma exchange therapy to remove the circulating autoantibodies and replenish ADAMTS13 enzyme activity. Additionally, corticosteroids and immunosuppressive drugs are often administered to control the underlying autoimmune response and prevent relapse.
Consultant Nephrologist and Transplant Physician, GM hospitals, Bangalore
Financial Disclosure
Comments
Comments
You must be logged in to leave a comment.